|
|
||||||||
Journal of Applied Physiology, Vol 79, Issue 6 2106-2113, Copyright © 1995 by American Physiological Society
ARTICLES |
C. Y. Pang, R. Z. Yang, P. Neligan, N. Xu, C. Chiu, A. Zhong and C. R. Forrest
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
We investigated the vascular effects and mechanism of action of endothelin-1 (ET-1) in the skin by intra-arterial infusion of ET-1 and its precursor Big ET-1 via a direct cutaneous artery in isolated perfused pig skin flaps (6 x 16 cm). The vascular contractivity was studied by monitoring the perfusion pressure in the skin flap. There was evidence to indicate local conversion of Big ET-1 to ET-1 in the pig skin. It was also observed that ET-1 was a potent long-lasting vasoconstrictor with a potency of approximately 10- and 300-fold higher than those of Big ET-1 and norepinephrine, respectively. The vasoconstrictor action of ET-1 was blocked (P < 0.01) by a selective ETA-receptor antagonist (BQ-123 or BQ-610; 10(-7) M) and enhanced (P < 0.05) by a nitric oxide synthase inhibitor (NG-monomethyl-L-arginine or N omega-nitro-L-arginine methyl ester; 10(-5) M). ET-1-induced increase in perfusion pressure was attenuated (P < 0.05) by an L-type Ca(2+)-channel antagonist (nitrendipine, verapamil, or nifedipine; 10(-5) M) and by removal of Ca2+ from the perfusate. ET-1-induced increase in perfusion pressure was also attenuated (P < 0.05) by a phospholipase C inhibitor (neomycin; 10(-2) M), a protein kinase C (PKC) inhibitor (chelerythrine or H-7; 10(-5) M), and an intracellular Ca2+ chelator [1,2-bis(2-aminophenoxy)]ethane-N,N,N',N'-tetraacetic acid (BAPTA); 10(-5) M]. Furthermore, it was observed that the concentration-dependent (5 x 10(-8) to 10(-5) M) increase in perfusion pressure induced by phorbol 12,13-dibutyrate, a PKC activator, was not affected by verapamil (10(-5) M) or removal of Ca2+ from the perfusate. Taken together, these observations suggest that the vasoconstrictor mechanism of ET-1 in the pig skin involved activation of ETA receptors, L-type Ca2+ channels, phospholipase C, and PKC and that the vasoconstrictor effect caused by activation of PKC was independent of L-type Ca2+ channels.
This article has been cited by other articles:
![]() |
H. Ashrafpour, N. Huang, P. C. Neligan, C. R. Forrest, P. D. Addison, M. A. Moses, R. H. Levine, and C. Y. Pang Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H946 - H954. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Black, N. Huang, P. C. Neligan, R. H. Levine, J. E. Lipa, S. Lintlop, C. R. Forrest, and C. Y. Pang Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1097 - R1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Pang, H. Xu, N. Huang, C. R. Forrest, T. M. Perreault, and P. C. Neligan Amplification effect and mechanism of action of ET-1 in U-46619-induced vasoconstriction in pig skin Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R713 - R720. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Lipa, P. C. Neligan, T. M. Perreault, J. Baribeau, R. H. Levine, R. J. Knowlton, and C. Y. Pang Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H359 - H367. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Pang, J. Zhang, H. Xu, J. E. Lipa, C. R. Forrest, and P. C. Neligan Role and mechanism of endothelin-B receptors in mediating ET-1-induced vasoconstriction in pig skin Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1066 - R1074. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |